Therapeutic Area

Antipsychotic

Therapeutic area intelligence for Antipsychotic with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 3
Catalysts: 0
Companies: 2

Companies

Novitium Pharma →

Torrent Pharmaceuticals →

Assets

Pimozide →

Risperidone →

Torrent →

Recent signals(3)

StrategyJune 21, 2026

FDA Grants AP Status for Risperidone ANDA077494 Submission

The FDA has granted an Abbreviated New Drug Application (ANDA) approval status for Risperidone under application number ANDA077494.

CompetitiveJune 10, 2026

Torrent's Lurasidone Hydrochloride ANDA Receives AP Status from FDA

Torrent's ANDA for Lurasidone Hydrochloride has received an Abbreviated Approval (AP) status from the FDA.

StrategyJune 9, 2026

FDA Grants Approval for Pimozide ANDA219897 by Novitium Pharma

The FDA has granted approval for ANDA219897, a generic formulation of Pimozide submitted by Novitium Pharma.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.